US 11,980,662 B2
Influenza virus vectors and uses therefor
Matthew Frederick LeFebvre, Roseville, MN (US); Yasuko Hatta, Madison, WI (US); Pamuk Bilsel, Madison, WI (US); and Michael J. Moser, Madison, WI (US)
Assigned to FluGen, Inc., Madison, WI (US)
Filed by FluGen, Inc., Madison, WI (US)
Filed on Feb. 18, 2022, as Appl. No. 17/675,297.
Application 17/675,297 is a continuation of application No. 16/676,119, filed on Nov. 6, 2019, granted, now 11,253,584.
Application 16/676,119 is a continuation of application No. 15/681,613, filed on Aug. 21, 2017, granted, now 10,500,267, issued on Dec. 10, 2019.
Application 15/681,613 is a continuation of application No. 15/125,763, granted, now 9,757,446, issued on Sep. 12, 2017, previously published as PCT/US2015/020580, filed on Mar. 13, 2015.
Claims priority of provisional application 61/954,346, filed on Mar. 17, 2014.
Prior Publication US 2023/0029543 A1, Feb. 2, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 7/00 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); C12N 7/01 (2006.01); C12N 7/04 (2006.01); C12N 15/44 (2006.01); C12N 15/86 (2006.01)
CPC A61K 39/145 (2013.01) [A61K 39/00 (2013.01); A61K 39/0011 (2013.01); A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/54 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/575 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16143 (2013.01); C12N 2760/16152 (2013.01)] 12 Claims
 
1. An immunogenic composition comprising the nucleic acid sequence of SEQ ID NO:35, wherein SEQ ID NO:35 further comprises a nucleic acid sequence encoding one or more antigens.